CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-03 | Kupiec James William Chief Medical Officer | Grant or award · Common Stock Warrant | +1,000 | 1,000 | ||
| 2024-01-03 | Schoen Eric Chief Financial Officer | Grant or award · Common Stock Warrant | +7,920 | 7,920 | ||
| 2024-01-03 | Schoen Eric Chief Financial Officer | Grant or award · Common Stock Warrant | +800 | 800 | ||
| 2023-12-06 | Nicaise Claude Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-12-06 | Gravier Pierre Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-12-06 | Anderson Robert Eugene Jr Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-10-03 | Schoen Eric Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-10-03 | Cook Robert Christopher SVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-10-03 | Kupiec James William Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-10-03 | BARBIER REMI President & CEO | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2023-10-03 | BARBIER REMI President & CEO | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2023-08-23 | ROBERTSON SANFORD Director | Purchase | +30,000 | $17.45 | $524K | 886,851 |
| 2023-08-22 | Barry Richard Director | Purchase | +16,571 | $16.65 | $276K | 293,477 |
| 2023-08-21 | Barry Richard Director | Purchase | +1,906 | $16.80 | $32K | 276,906 |
| 2023-06-12 | SCANNON PATRICK J MD PHD Director | Option exercise | +1,000 | $0.95 | $950 | 1,000 |
| 2023-06-12 | SCANNON PATRICK J MD PHD Director | Option exercise · Stock Option (Right to Buy) | −1,000 | $0.95 | $950 | 9,000 |
| 2023-05-24 | BARBIER REMI President and CEO | Option exercise | +14,285 | $16.87 | $241K | 390,397 |
| 2023-05-24 | BARBIER REMI President and CEO | Shares withheld for taxes | −9,545 | $25.25 | $241K | 380,852 |
| 2023-05-24 | BARBIER REMI President and CEO | Option exercise | +71,428 | $16.87 | $1.2M | 782,002 |
| 2023-05-24 | BARBIER REMI President and CEO | Shares withheld for taxes | −47,723 | $25.25 | $1.2M | 734,279 |
Page 4 of 17 · 324 trades